This study provides evidence suggesting that the IFNγ-mediated JAKs-STATs axis plays a double-edged sword in NSCLC stimulating reactivation of CD8+ T cells but increasing anti-apoptosis MCL1 expression in A549. The gene discussed is MCL1; the disease is non-small cell lung carcinoma.